$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Neurology
Neurology
trofinetide(Daybue)说明书,用法用量,作用功效,注意事项及购买渠道?
2025-10-19 11:44:20
Check Details
trofinetide(Daybue)治疗Rett综合征的效果如何?
2025-10-19 11:44:20
Check Details
Daybue用后副作用大吗,怎么处理?
2025-10-19 11:44:20
Check Details
FDA批准首个Rett综合征治疗药物trofinetide(Daybue)
2025-10-19 11:44:20
Check Details
Daybue(曲非肽)治疗Rett综合征的疗效
2025-10-19 11:44:20
Check Details
Daybue(曲非肽):Rett综合征患者的新希望
2025-10-19 11:44:20
Check Details
首个Rett综合征治疗药trofinetide(Daybue)获FDA批准上市
2025-10-19 11:44:20
Check Details
曲非肽治疗Rett综合征的作用疗效简介
2025-10-19 11:44:20
Check Details
Rett综合征用药曲非肽的副作用及注意事项介绍
2025-10-19 11:44:20
Check Details
曲非肽在雷特综合征中的临床疗效分析
2025-10-19 11:44:20
Check Details
曲非肽:一种用于Rett综合征的治疗方法解析
2025-10-19 11:44:20
Check Details
Rett综合征药物曲非肽的作用机制和购买方式简介
2025-10-19 11:44:20
Check Details
1
2
...
153
154
155
156
157
158
159
...
253
254
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Lemborexant for Insomnia: Dual Orexin 5/10mg, 7-Hour Bedtime, 7–10-Day Review and Safety
2
Vorasidenib Continuous Therapy Guide: Dosing Strategy and Management for Glioma
3
Vigabatrin (Sabril): Mechanism of Action, Pharmacokinetics, and Safety Monitoring
4
Sabril (Vigabatrin) Explained: Indications, Vision Loss Risk & Key Warnings
5
Elamipretide Side Effects and Medication Safety Guide: Injection Site Reactions and Storage Essentials
6
Simtriyo (Centanafadine): World's First NDSRI ADHD Drug Approved by FDA
7
Brivaracetam Medication and Discontinuation Safety Guide
8
Lemborexant: Mechanism of Action and Clinical Profile of a Dual Orexin Receptor Antagonist
9
Omaveloxolone (Skyclarys): Side Effect Management and Clinical Guide for Friedreich’s Ataxia
10
Omaveloxolone Mechanism of Action and Clinical Application Guide
11
Lemborexant: A Dual Orexin Receptor Antagonist Revolutionizing Insomnia Treatment
12
Benzgalantamine (Zunveyl) for Alzheimer's Disease: Efficacy and Optimal Treatment Stages